Contribution of the Evaluation of Body Composition by Connected Scale in the Effectiveness of a Reconditioning Program Through Physical Activity Adapted for Patients Suffering From Chronic Diseases (COCORAPA)

September 30, 2025 updated by: Assistance Publique - Hôpitaux de Paris

The goal of this interventional study is to evaluate the impact of the use of a connected impedance scale on the physical and mental quality of life of patients suffering from chronic diseases and participating in a physical activity rehabilitation program. The main objective is to know if a regular monitoring of the evolution of body composition parameters recorded by the connected scale would allow patients participating in the Physical Activity rehabilitation program at Hôtel-Dieu to follow in real time the effects of such program, not on weight itself but on body composition, and that this would contribute to a better perception of physical and mental quality of life at the end of the program 90 Participants will be randomized in two groups :

  • Control group (N = 45) : routine care
  • Interventionnal group (N=45) : routine care + use of connected scale All participants will undergo physical activity rehabilitation program during 6 weeks.

Patients will be see again at 6 months, and the following parameters will be comparer between the two groups :

  • SF-36 questionnaire
  • Ricci & Gagnon questionnaire
  • 6MWT
  • 30 sec sit-to stand test
  • Ito-Shirado test
  • Sorensen test
  • Handgrip test
  • MaxV02

Study Overview

Status

Active, not recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Paris, France, 75181 Paris Cedex 04
        • Centre d'Investigations en Médecine du Sport - Hôpital Hôtel Dieu

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patient (male or female) aged 18 and over
  • Patient able to express free, informed and written consent
  • Patient participating in the physical activity rehabilitation program at the CIMS of the Hôtel Dieu
  • Patient suffering from a known, stable and diagnosed chronic disease
  • Patient autonomous in taking treatments for their ALD
  • Patient affiliated to a social security system

Exclusion Criteria:

  • Patient under legal protection (guardianship, curatorship)
  • Patient deprived of liberty by a judicial or administrative decision
  • Patient with functional limitations that do not allow a physical assessment or result in a walking distance < 350 m during the HDJ for admission to the program
  • Patient with suspected cardiac pathology during the HDJ for admission to the program
  • Patient with episode of decompensation or exacerbation
  • Patient with a pacemaker or implantable automatic defibrillator
  • Pregnant women

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Standard follow-up group
Routine care
Experimental: Connected scale group
Routine care + use of connected scale during 6 months
Patients in the intervention group will use the connected scale at a minimum frequency of once a week from receipt of the scale and throughout their participation in the research (6 months)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measurement of the physical and mental quality of life score using the Short Form 36 questionnaire at 6 months for each patient.
Time Frame: 6 months from initiation of physical activity rehabilitation program
Short Form 36 questionnaire (0 - 100 ; Higher mean better outcome)
6 months from initiation of physical activity rehabilitation program

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measurement of the physical and mental quality of life score using the Short Form 36 questionnaire at 6 weeks for each patient.
Time Frame: 6 weeks from initiation of physical activity rehabilitation program
Short Form 36 questionnaire (0 - 100 ; Higher mean better outcome)
6 weeks from initiation of physical activity rehabilitation program
Measurement of daily physical activity level by the Ricci & Gagnon questionnaire at 6 months for each patient
Time Frame: 6 months from initiation of physical activity rehabilitation program
Ricci & Gagnon questionnaire (9 - 45 ; Higher mean better outcome)
6 months from initiation of physical activity rehabilitation program
Measurement of 6 minute walk test (6MWT) at 6 months for each patient
Time Frame: 6 months from initiation of physical activity rehabilitation program
6 minute walk test (Higher mean better outcome)
6 months from initiation of physical activity rehabilitation program
Measurement of 30 sec sit-to-stand test at 6 months for each patient
Time Frame: 6 months from initiation of physical activity rehabilitation program
30 sec sit-to-stand test (Higher mean better outcome)
6 months from initiation of physical activity rehabilitation program
Measurement of Ito-Shirado test at 6 months for each patient
Time Frame: 6 months from initiation of physical activity rehabilitation program
Ito-Shirado test (Higher mean better outcome)
6 months from initiation of physical activity rehabilitation program
Measurement of Sorensen test at 6 months for each patient
Time Frame: 6 months from initiation of physical activity rehabilitation program
Sorensen test (Higher mean better outcome)
6 months from initiation of physical activity rehabilitation program
Measurement of Handgrip test at 6 months for each patient
Time Frame: 6 months from initiation of physical activity rehabilitation program
Handgrip test (Higher mean better outcome)
6 months from initiation of physical activity rehabilitation program
Measurement of VO2max at 6 months for each patient
Time Frame: 6 months from initiation of physical activity rehabilitation program
VO2
6 months from initiation of physical activity rehabilitation program

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 27, 2024

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 1, 2026

Study Registration Dates

First Submitted

October 16, 2023

First Submitted That Met QC Criteria

October 31, 2023

First Posted (Actual)

November 7, 2023

Study Record Updates

Last Update Posted (Estimated)

October 1, 2025

Last Update Submitted That Met QC Criteria

September 30, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • APHP230549
  • 2023-A01156-39 (Other Identifier: IDRCB)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Disease

Clinical Trials on Body Comp Pro connected scale (Withings manufacturer)

Subscribe